Medicare Enrolled
Dr. Michael Como, M.D.
Pulmonary Disease · Great Neck, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Como from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Como?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Como
Dr. Michael Como is a pulmonary disease specialist in Great Neck, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Como performed 3,569 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Como received a total of $18,355 from 43 pharmaceutical and/or device companies across 712 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Como is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 9% volume in NY
$18,355 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,569
Medicare services
Top 9% in NY for pulmonary disease
Not available
Unique patients (not deduplicated)
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
639 | $110 | $406 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
549 | $73 | $270 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
357 | $114 | $442 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
349 | $26 | $96 |
| Chest X-ray, 1 view An X-ray image of the chest taken from a single angle. This imaging test is used to visualize the structures within the chest cavity. |
321 | $25 | $94 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
295 | $200 | $735 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
187 | $160 | $591 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
163 | $122 | $447 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
150 | $53 | $194 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
150 | $53 | $203 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
109 | $79 | $313 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
57 | $37 | $138 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
55 | $143 | $579 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
44 | $76 | $200 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
43 | $36 | $85 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
41 | $169 | $576 |
| Same-day hospital admission and discharge, moderate complexity This code covers initial hospital care for a patient admitted and discharged on the same day. It applies when the visit involves moderate medical decision making and lasts at least 70 minutes. |
23 | $140 | $542 |
| Chest fluid aspiration with imaging guidance This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement. |
19 | $99 | $373 |
| Chest fluid drainage with tube insertion using imaging guidance This procedure removes fluid from the chest cavity and places a tube to stay in place for ongoing drainage. Imaging guidance is used to help position the tube accurately. |
18 | $140 | $511 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$18,355
Total received (2018-2024)
Avg $2,622/year across 7 years
Top 12% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
712
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,402
2023
$2,858
2022
$2,694
2021
$3,015
2020
$1,468
2019
$2,620
2018
$2,297
Payments by company (2024)
ATRICURE, INC.
$637
GlaxoSmithKline, LLC.
$531
AstraZeneca Pharmaceuticals LP
$501
Actelion Pharmaceuticals US, Inc.
$274
Boehringer Ingelheim Pharmaceuticals, Inc.
$222
Regeneron Healthcare Solutions, Inc.
$160
Baxter Healthcare
$157
Mylan Specialty L.P.
$145
Philips North America LLC
$129
Novartis Pharmaceuticals Corporation
$106
United Therapeutics Corporation
$78
Electromed, Inc.
$73
GENZYME CORPORATION
$69
Astellas Pharma US Inc
$61
Genentech USA, Inc.
$58
Vifor Pharma, Inc.
$52
Takeda Pharmaceuticals U.S.A., Inc.
$32
Mallinckrodt Hospital Products Inc.
$30
Shionogi Inc
$25
Insmed, Inc.
$25
Grifols USA, LLC
$20
Merck Sharp & Dohme LLC
$17
Top 3 companies account for 49.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$4,288
AstraZeneca Pharmaceuticals LP
$2,244
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,742
United Therapeutics Corporation
$1,134
Actelion Pharmaceuticals US, Inc.
$1,041
Philips Electronics North America Corporation
$780
GENZYME CORPORATION
$708
Genentech USA, Inc.
$658
ATRICURE, INC.
$637
Sunovion Pharmaceuticals Inc.
$556
Baxter Healthcare
$478
Mylan Specialty L.P.
$462
Novartis Pharmaceuticals Corporation
$417
Amgen Inc.
$355
Regeneron Healthcare Solutions, Inc.
$348
Insmed, Inc.
$284
Electromed, Inc.
$253
Advanced Respiratory, Inc
$236
Grifols USA, LLC
$217
Janssen Pharmaceuticals, Inc
$217
Mallinckrodt Hospital Products Inc.
$206
Philips North America LLC
$129
Olympus America Inc.
$125
Pulmonx Corporation
$125
Shionogi Inc
$67
Mallinckrodt Enterprises LLC
$64
Astellas Pharma US Inc
$61
Gilead Sciences, Inc.
$54
Vifor Pharma, Inc.
$52
Inogen, Inc.
$47
Takeda Pharmaceuticals U.S.A., Inc.
$47
La Jolla Pharmaceutical Company
$44
ADVANCED RESPIRATORY, INC
$44
Merck Sharp & Dohme Corporation
$42
Circassia Pharmaceuticals Inc
$39
PFIZER INC.
$39
Otsuka America Pharmaceutical, Inc.
$21
Inari Medical, Inc.
$20
Alexion Pharmaceuticals, Inc.
$17
Merck Sharp & Dohme LLC
$17
Chiesi USA, Inc.
$16
Shire North American Group Inc
$15
E.R. Squibb & Sons, L.L.C.
$11
Top 3 companies account for 45.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (8944) Trilogy Evo Universal · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · ATRICLIP LAA EXCLUSION SYSTEM · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CLEVIPREX · DUPIXENT · Dymista · ELIQUIS · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Esbriet · FASENRA · Fetroja · FlowTriever · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hillrom - Vest System Model 205 Acute Care · Hillrom - VisiVest Airway Clearance System · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · InogenOne · JARDIANCE · LONHALA MAGNAIR · Letairis · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · Respiratoriy Care Undiv · SAMSCA · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest 104 · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · Trilogy 100 · ULTOMIRIS · UPTRAVI · UTIBRON · UTIBRON NEOHALER · Utibron · Veozah · WINREVAIR · Wellcentive Undiv · XARELTO · XOLAIR · Xolair · YUPELRI · Yupelri · Zemaira · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
628
County median income
$143,408
Nearest hospital to ZIP centroid (approximate)
NORTH SHORE UNIVERSITY HOSPITAL
2.4 mi
2.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Como is a clinical cardiology specialist, with above-average Medicare volume (top 9% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Como experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Como performed 639 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Como receive payments from pharmaceutical companies?
Yes. Dr. Como received a total of $18,355 from 43 companies across 712 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Como's costs compare to other pulmonary diseases in Great Neck?
Dr. Como's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Como) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Great Neck
Browse pulmonary diseases in Great Neck ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology